4-168878158-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The ENST00000507735.6(PALLD):​c.267G>C​(p.Pro89Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P89P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.012 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PALLD
ENST00000507735.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.98

Publications

1 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 4-168878158-G-C is Benign according to our data. Variant chr4-168878158-G-C is described in ClinVar as Benign. ClinVar VariationId is 215804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.98 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PALLDNM_001166108.2 linkc.1965-12764G>C intron_variant Intron 10 of 21 ENST00000505667.6 NP_001159580.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PALLDENST00000505667.6 linkc.1965-12764G>C intron_variant Intron 10 of 21 1 NM_001166108.2 ENSP00000425556.1

Frequencies

GnomAD3 genomes
AF:
0.00142
AC:
183
AN:
129164
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00271
Gnomad AMI
AF:
0.00133
Gnomad AMR
AF:
0.000837
Gnomad ASJ
AF:
0.000311
Gnomad EAS
AF:
0.00179
Gnomad SAS
AF:
0.00308
Gnomad FIN
AF:
0.00403
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.00168
GnomAD2 exomes
AF:
0.0161
AC:
1152
AN:
71534
AF XY:
0.0128
show subpopulations
Gnomad AFR exome
AF:
0.0627
Gnomad AMR exome
AF:
0.0513
Gnomad ASJ exome
AF:
0.0143
Gnomad EAS exome
AF:
0.0169
Gnomad FIN exome
AF:
0.00958
Gnomad NFE exome
AF:
0.00922
Gnomad OTH exome
AF:
0.0172
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0115
AC:
7237
AN:
629276
Hom.:
0
Cov.:
30
AF XY:
0.0107
AC XY:
3385
AN XY:
315000
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0217
AC:
243
AN:
11194
American (AMR)
AF:
0.0525
AC:
709
AN:
13508
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
136
AN:
10668
East Asian (EAS)
AF:
0.00896
AC:
55
AN:
6138
South Asian (SAS)
AF:
0.00674
AC:
360
AN:
53404
European-Finnish (FIN)
AF:
0.00966
AC:
100
AN:
10356
Middle Eastern (MID)
AF:
0.0165
AC:
29
AN:
1756
European-Non Finnish (NFE)
AF:
0.0106
AC:
5295
AN:
498798
Other (OTH)
AF:
0.0132
AC:
310
AN:
23454
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.257
Heterozygous variant carriers
0
946
1891
2837
3782
4728
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00140
AC:
181
AN:
129240
Hom.:
0
Cov.:
32
AF XY:
0.00130
AC XY:
82
AN XY:
62876
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00271
AC:
91
AN:
33574
American (AMR)
AF:
0.000835
AC:
11
AN:
13174
Ashkenazi Jewish (ASJ)
AF:
0.000311
AC:
1
AN:
3218
East Asian (EAS)
AF:
0.00179
AC:
7
AN:
3910
South Asian (SAS)
AF:
0.00279
AC:
10
AN:
3582
European-Finnish (FIN)
AF:
0.00403
AC:
31
AN:
7690
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
266
European-Non Finnish (NFE)
AF:
0.000424
AC:
26
AN:
61264
Other (OTH)
AF:
0.00166
AC:
3
AN:
1808
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.255
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00816
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

not specified Benign:1
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Pancreatic adenocarcinoma Benign:1
Sep 10, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.87
DANN
Benign
0.59
PhyloP100
-3.0
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs863224384; hg19: chr4-169799309; COSMIC: COSV107223711; API